Lepas L8: China’s New SUV Means Business August 10, 2026 Is the UK’s SUV market ready for another Chinese challenger? Motoring journalist Tim Barnes-Clay takes a closer look at the new Lepas. Lepas, another new marque from automotive giant Chery – the company behind Omoda and Jaecoo – is positioning the L8 plug-in hybrid (PHEV) as a premium SUV that combines handsome styling, generous technology [...]
AT&T-Led Neutral-Host Network Powers New Connectivity Experience at Davis Wade Stadium August 10, 2026 AT&T customers at Mississippi State University’s Davis Wade Stadium in Starkville are getting a boost in wireless connectivity following the deployment of a new AT&T-led distributed antenna system, or DAS, powered by Airspan’s MobileAccess 6000 Digital platform. Led and owned by AT&T as a neutral-host network, the new DAS is designed to deliver high-capacity, multi-operator [...]
Cavendish taps top adviser to fend off foreign takeover interest August 10, 2026 Cavendish has drafted in advisers from a top corporate consultancy to help it fend off low-ball takeover bids amid a wave of consolidation in Britain’s financial services sector. Top brass at the boutique investment bank enlisted the help of specialists at Teneo last year, City AM can reveal, who conducted a valuation exercise to “support [...]
Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile August 10, 2026 Trial met its primary endpoint, with a significantly higher proportion of clinical responders on divesiran (88%) compared to placebo (19%); placebo-adjusted response rate = 69% Both divesiran dose groups showed substantial primary endpoint efficacy; 93.8% response rate at Q6W and 81.3% response rate at Q12W Divesiran was observed to be well tolerated with no new safety findings Phase 3 PV trial evaluating divesiran Q12W vs. placebo anticipated to initiate in 1H’27 Investor conference call and webcast to be held today, August 10, 2026 at 8:00 a.m. ET
Silence Therapeutics Reports Second Quarter 2026 Financial and Business Results August 10, 2026 Silence Therapeutics plc, (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today reported its financial and business results for the second quarter ended June 30, 2026. Business Highlights Divesiran: First-in-class siRNA silencing TMPRSS6 for polycythemia vera (PV) and other blood disorders Presented follow-up data from the Phase 1 SANRECO trial [...]
‘Good growth in every postcode’ is a woeful catchphrase August 10, 2026 Burnham and co's bid to 'back British' and generate 'good growth' everywhere is a bid to fool voters with their own money, writes Eliot Wilson.
Silence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera August 9, 2026 Silence Therapeutics plc, (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced a conference call and webcast to discuss topline results from the Phase 2 SANRECO trial of divesiran in polycythemia vera (PV) scheduled for tomorrow, Monday, August 10, 2026 at 8:00 a.m. EDT. Investor Webcast & Conference Call [...]
Stop burying us in swollen corporate reports, says audit watchdog boss August 9, 2026 The boss of the audit watchdog has warned that the size of annual reports has swelled out of control, costing directors too much time. Richard Moriarty, chief executive of the Financial Reporting Council, said the costs and expectations surrounding annual reports have steadily ballooned as more companies devote pages to environmental, social and governance issues [...]
Algoma Central Corporation Reports Financial Results for the 2026 Second Quarter August 7, 2026 Strategic acquisitions, expanded credit facilities, and strong segment performance position Algoma for continued growth.
Battery Ventures Promotes Brandon Gleklen to Partner August 7, 2026 Gleklen, who invests in AI-application companies, joins new principal Jason Mendel and eight other investors globally promoted to new roles